Signal2026-07-02
ClinicalTrials.gov

[PHASE2] Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Part of

Emerging Cancer Biomarker Techniques

Open primary sourceRead on Substack